BackIntercept Pharmaceuticals Overview

Intercept Pharmaceuticals Total Revenue

Revenue analysis for ICPT.

Quarterly Revenue

$88.79M
↑ 14.44% YoY

As of Sep 2023

Annual Revenue (TTM)

$288.25M
↓ 12.74% YoY

Trailing 12 months ending Sep 2023

Average Revenue (Comparison Companies)

Loading

Total Revenue History

Loading

Total Revenue Comparison

Loading

Annual Revenue Growth Rate (%)

Loading

Annual Revenue Growth (Absolute)

Loading
Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin